| Product Code: ETC11227182 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of type 2 diabetes drugs and devices to Ireland in 2024 saw a significant increase in concentration, with Germany, UK, USA, Canada, and other areas being the top exporting countries. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market. The impressive Compound Annual Growth Rate (CAGR) of 23.25% from 2020 to 2024 and a substantial growth rate of 68.68% from 2023 to 2024 suggest a thriving market for diabetes-related products in Ireland, driven by imports from key global players.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Type 2 Diabetes Drugs and Devices Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, 2022 & 2032F |
3.3 Ireland Type 2 Diabetes Drugs and Devices Market - Industry Life Cycle |
3.4 Ireland Type 2 Diabetes Drugs and Devices Market - Porter's Five Forces |
3.5 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Drug Class, 2022 & 2032F |
3.7 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Device Type, 2022 & 2032F |
3.8 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By End Use, 2022 & 2032F |
4 Ireland Type 2 Diabetes Drugs and Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of type 2 diabetes in Ireland |
4.2.2 Technological advancements in diabetes drugs and devices |
4.2.3 Growing awareness about the importance of diabetes management |
4.3 Market Restraints |
4.3.1 Stringent regulations governing the approval and marketing of diabetes drugs and devices |
4.3.2 High cost associated with diabetes treatment |
4.3.3 Limited reimbursement options for diabetes drugs and devices |
5 Ireland Type 2 Diabetes Drugs and Devices Market Trends |
6 Ireland Type 2 Diabetes Drugs and Devices Market, By Types |
6.1 Ireland Type 2 Diabetes Drugs and Devices Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Oral Drugs, 2022 - 2032F |
6.1.4 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Injectables, 2022 - 2032F |
6.1.5 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Insulin Therapy, 2022 - 2032F |
6.1.6 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Combination Therapy, 2022 - 2032F |
6.2 Ireland Type 2 Diabetes Drugs and Devices Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Metformin, 2022 - 2032F |
6.2.3 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By SGLT2 Inhibitors, 2022 - 2032F |
6.2.4 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By GLP-1 Agonists, 2022 - 2032F |
6.2.5 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By DPP-4 Inhibitors, 2022 - 2032F |
6.3 Ireland Type 2 Diabetes Drugs and Devices Market, By Device Type |
6.3.1 Overview and Analysis |
6.3.2 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Glucose Monitors, 2022 - 2032F |
6.3.3 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Insulin Pumps, 2022 - 2032F |
6.3.4 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By CGMs, 2022 - 2032F |
6.3.5 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Smart Insulin Pens, 2022 - 2032F |
6.4 Ireland Type 2 Diabetes Drugs and Devices Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.4.4 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Pharmacies, 2022 - 2032F |
6.4.5 Ireland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Home Care, 2022 - 2032F |
7 Ireland Type 2 Diabetes Drugs and Devices Market Import-Export Trade Statistics |
7.1 Ireland Type 2 Diabetes Drugs and Devices Market Export to Major Countries |
7.2 Ireland Type 2 Diabetes Drugs and Devices Market Imports from Major Countries |
8 Ireland Type 2 Diabetes Drugs and Devices Market Key Performance Indicators |
8.1 Percentage of diabetic population using advanced diabetes drugs and devices |
8.2 Adoption rate of new diabetes management technologies in Ireland |
8.3 Number of clinical trials and research studies focusing on type 2 diabetes in Ireland |
9 Ireland Type 2 Diabetes Drugs and Devices Market - Opportunity Assessment |
9.1 Ireland Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Ireland Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Drug Class, 2022 & 2032F |
9.3 Ireland Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Device Type, 2022 & 2032F |
9.4 Ireland Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By End Use, 2022 & 2032F |
10 Ireland Type 2 Diabetes Drugs and Devices Market - Competitive Landscape |
10.1 Ireland Type 2 Diabetes Drugs and Devices Market Revenue Share, By Companies, 2025 |
10.2 Ireland Type 2 Diabetes Drugs and Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here